Document is current
Any future updates will be listed below
-
Authors
West, Erin A.
Kotoun, Olivia J.
Schori, Larissa J.
Kopp, Julia
Kaufmann, Marco
Rasi, Manuela
Fehr, Jan
Puhan, Milo A.
Frei, Anja https://orcid.org/0000-0002-7134-1000
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
isrctn18181860 at ISRCTN.orgDocuments that mention this clinical trial
Seroprevalence of SARS-CoV-2 antibodies, associated factors, experiences and attitudes of nursing home and home healthcare employees in Switzerland
https://doi.org/10.1186/s12879-022-07222-8
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
https://doi.org/10.1136/bmj-2022-074425
Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland
https://doi.org/10.1136/bmjopen-2020-047483
-
Funding
Funding for this research was provided by:
swiss federal office of public health
swiss school of public health
universität zürich
- License Information
-
More Information
Article History
Received: 14 July 2021
Accepted: 1 March 2022
First Online: 16 March 2022
Declarations
:
: The study was approved by the Kantonale Ethikkommission Zürich, the responsible ethics commission of the canton Zurich, Switzerland (BASEC No 2020-01247). ISRCTN Registry: . The subjects of the study were provided informed consent (included in submission) prior to their participation in the study and written, informed consent was obtained for all participants. This cohort study has been deemed a “Category A” research project according to HRO Art. 7, as the planned data collection entails only minimal risks and burden to patients.
: Not applicable.
: We declare that we have no conflict of interest.
